Showing 21 of 25 results

Oxford Policy Management and UNICEF
Report that outlines the findings from the study on COVID-19 vaccine demand promotion drawing on the qualitative data gathered from Ethiopia, Rwanda, South Africa and South Sudan,Report that outlines...
UNICEF, World Health Organization
Revue sur l'expérience du Rwanda en matière de mise à l’échelle de méthodes de suivi en temps réel et d’utilisation de solutions numériques pour renforcer la surveillance de la COVID-19,...
UNICEF, World Health Assembly
Highlighting Rwanda’s Experience Scaling Real-time Monitoring Approaches Using Digital Solutions to Support COVID-19 Surveillance, COVID-19 Vaccination and Case Management,Highlighting Rwanda’s...
R Wong, D Wanyana, D Hakizimana
The objective of this study is to assess the change in the utilization of maternal and child health (MCH) services during the COVID-19 outbreak.
Richard Mihigo, Alain Poy, Jethro Chakauya, Abubacar N’Diaye, Bernard Ntsama, Messeret Eshetu Shibeshi, Richard Luce, Balcha Girma Masresha
This study reviews the administrative routine immunization data from 15 African countries for the period from January 2018 to June 2020 to analyze the trends in the monthly number of children...
These slides were presented at the Global Immunization Meeting in Kigali, Rwanda in June 2018 on empowering health workers for immunization data analysis and use.
Marie Paul Nisingizwe, Hari S. Iyer, Modeste Gashayija, Lisa R. Hirschhorn, Cheryl Amoroso, Randy Wilson, Eric Rubyutsa, Eric Gaju, Paulin Basinga, Andrew Muhire, Agnès Binagwaho, Bethany Hedt-Gauthier1
Background Health data can be useful for effective service delivery, decision making, and evaluating existing programs in order to maintain high quality of healthcare. Studies have shown variability...
Home-based record (HBR) for Rwanda circa 2012
Home-based record (HBR) for Rwanda circa 2012 (maternal)
Home-based record (HBR) for Rwanda circa 2014 (female)
Home-based record (HBR) for Rwanda circa 2014 (male)
Despite its promise, however, the digital health landscape today is highly fragmented. The result is a myriad of digital health projects and applications that rarely reach scale and if they were to...
María Clara Restrepo-Méndez et al.
Despite the improvements made in global immunization coverage for children over the past decade,1,2 an estimated 21.8 million infants worldwide are still not being reached by routine immunization...
Rurangwa J & Rujeni N
Pneumonia is a public health problem in the tropics, and the 7-valent pneumococcal conjugative vaccine (PCV-7) has been introduced in an effort to prevent the disease and therefore reduce childhood...
Maurice Gatera et al.
As the pace of vaccine uptake accelerates globally, there is a need to document low-income country experiences with vaccine introductions. Over the course of five years, the government of Rwanda...
Jacqueline E. Tate et al.
Background. Rotavirus vaccine efficacy is lower in low-income countries than in high-income countries. Rwanda was one of the first low-income countries in sub-Saharan Africa to introduce rotavirus...
Christine McNab, Tracey Goodman & Susan Wang
This report presents communication guidance and specific considerations for countries that plan to introduce human papillomavirus (HPV) vaccine into their national immunization programme. New vaccine...
World Health Organization
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...
Fidèle Ngabo et al.
The number of admissions to hospital for diarrhoea and rotavirus in Rwanda fell substantially after rotavirus vaccine implementation, including among older children age-ineligible for vaccination,...
Fidèle Ngabo et al.
Detailed cost evaluations of delivery of new vaccines such as pneumococcal conjugate, human papillomavirus (HPV), and rotavirus vaccines in low and middle-income countries are scarce. This paper...
Kathleen Tiffay et al.
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...